The borderline or weakly positive Hybrid Capture II HPV test: A statistical and comparative (PCR) analysis

作者: Jerome M. Federschneider , Liping Yuan , Joshua Brodsky , Gillian Breslin , Rebecca A. Betensky

DOI: 10.1016/J.AJOG.2004.03.077

关键词:

摘要: Abstract Objectives Recent studies have hypothesized that laboratory contamination may influence interpretation of Hybrid Capture II (HCII) human papillomavirus (HPV) detection assay values. Study design To test this hypothesis, 572 consecutive HCII samples were statistically evaluated to the null hypothesis cross-well was not present. In addition, 874 paired from patients followed by both and polymerase chain reaction (PCR) analysis compared. Results A Kendall's tau measure association among adjacent wells yielded a P value .016, rejecting no contamination. Analysis relative light unit values between 0.8 1.5 rejected at P = .077. Moreover, PCR positivity significantly higher for with above vs (P = .001). Conclusion Cross-well occurs during processing, some borderline positives. The proportion cases risk is low (

参考文章(20)
J Cuzick, E Beverley, L Ho, G Terry, H Sapper, I Mielzynska, A Lorincz, W-K Chan, T Krausz, P Soutter, HPV testing in primary screening of older women. British Journal of Cancer. ,vol. 81, pp. 554- 558 ,(1999) , 10.1038/SJ.BJC.6690730
Mark Schiffman, Patti E. Gravitt, Robert Tarone, Mark E. Sherman, Sophia S. Wang, Cosette M. Wheeler, Laurie Rich, Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiology, Biomarkers & Prevention. ,vol. 12, pp. 1038- 1044 ,(2003)
Diane Solomon, Mark Schiffman, Robert Tarone, None, Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial Journal of the National Cancer Institute. ,vol. 93, pp. 293- 299 ,(2001) , 10.1093/JNCI/93.4.293
P. E. Castle, A. T. Lorincz, I. Mielzynska-Lohnas, D. R. Scott, A. G. Glass, M. E. Sherman, J. E. Schussler, M. Schiffman, Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible Journal of Clinical Microbiology. ,vol. 40, pp. 1088- 1090 ,(2002) , 10.1128/JCM.40.3.1088-1090.2002
Patricia de Cremoux, Joël Coste, Xavier Sastre-Garau, Martine Thioux, Christelle Bouillac, Sylvain Labbé, Isabelle Cartier, Marianne Ziol, Anne Dosda, Catherine Le Galès, Vincent Molinié, Marie-Cécile Vacher-Lavenu, Béatrix Cochand-Priollet, Philippe Vielh, Henri Magdelénat, , Efficiency of the Hybrid Capture 2 HPV DNA Test in Cervical Cancer Screening American Journal of Clinical Pathology. ,vol. 120, pp. 492- 499 ,(2003) , 10.1309/XFUCPP6M5XUA94B8
MM Manos, M. Manos, AI Lewis, Y Ting Shin, TR Broker, DK Wright, YC Ting, SM Wolinsky, The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses ,(1989)
Francisco Garcia, Karl Ulrich Petry, Laila Muderspach, Michael A Gold, Patricia Braly, Christopher P Crum, Marianne Magill, Michael Silverman, Robert G Urban, Mary Lynne Hedley, Kathleen J Beach, None, ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial Obstetrics & Gynecology. ,vol. 103, pp. 317- 326 ,(2004) , 10.1097/01.AOG.0000110246.93627.17
Jean-Paul Bory, Jo�l Cucherousset, Marianne Lorenzato, Ren� Gabriel, Christian Quereux, Philippe Birembaut, Christine Clavel, Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. International Journal of Cancer. ,vol. 102, pp. 519- 525 ,(2002) , 10.1002/IJC.10735